Molecular Diagnosis & Therapy

Papers
(The TQCC of Molecular Diagnosis & Therapy is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
ADORA3: A Key Player in the Pathogenesis of Intracranial Aneurysms and a Potential Diagnostic Biomarker135
The Role of MicroRNAs in the Pathogenesis and as Biomarkers for Pediatric Epilepsy: A Systematic Review79
Predictive Ability of Serum Amino Acid Levels to Differentiate Fibromyalgia Patients from Healthy Subjects79
Comment on “Prognostic and Clinical Significance of Human Leukocyte Antigen Class I Expression in Breast Cancer: A Meta‑Analysis”58
Personalized Cancer Monitoring Assay for the Detection of ctDNA in Patients with Solid Tumors56
Indirect Clinical Validation of a Programmed Death-Ligand 1 Laboratory-Developed Test for Gastric/Gastroesophageal Junction Adenocarcinoma with 22C3 Antibody Concentrate56
Gene Therapy for Cardiomyocyte Renewal: Cell Cycle, a Potential Therapeutic Target41
Expression Signature of Immune-Related MicroRNAs in Autoimmune Skin Disease: Psoriasis and Vitiligo Insights39
Evaluation of Minimal Residual Disease in Patients with Neuroblastoma36
Personalized Medicine in Cystic Fibrosis: Characterization of Eight Rare CFTR Variants in Intestinal Organoids and Cellular Models36
FAPI-Targeted Molecular Imaging: Transforming Insights into Post-Ischemic Myocardial Remodeling?35
Drug Hypersensitivity Reactions in Patients with Cystic Fibrosis: Potential Value of the Lymphocyte Toxicity Assay to Assess Risk35
The Role of Non-coding RNAs in Connective Tissue Diseases: Diagnostic and Therapeutic Potential of miRNAs, lncRNAs and circRNAs34
Research Progress on Signal Conversion Based on Aptamer Combined CRISPR/Cas System in Biosensors32
Prediction of Biomarker Expression on Primary Pancreatic Ductal Adenocarcinoma Tissues Using Fine-Needle Biopsies: Paving the Way for a Patient-Tailored Molecular Imaging Approach31
Correction to: Revakinagene Taroretcel: First Approval31
Recent Advancements in Nanomaterials: A Promising Way to Manage Neurodegenerative Disorders28
Inflammatory Gene Panel Guiding the Study of Genetics in Inflammatory Bowel Disease26
Fatty Acid Desaturase: The Yin or Yang of Disease Pathology25
Personalizing Oncolytic Immunovirotherapy Approaches24
Afamitresgene Autoleucel: First Approval23
Clinical Metagenomic Next-Generation Sequencing for Diagnosis of Central Nervous System Infections: Advances and Challenges23
Glioma 2021 WHO Classification: The Superiority of NGS Over IHC in Routine Diagnostics23
Development of a Nomogram to Predict Therapeutic Resistance in Metastatic Melanoma Using Longitudinal ctDNA Kinetics23
Comment on “The Diagnostic and Prognostic Value of miR‑155 in Cancers: An Updated Meta‑analysis”22
Advances and Challenges in the Diagnosis of Leishmaniasis22
Long-Range PCR and Nanopore Sequencing Enables High-Throughput Detection of TCF4 Trinucleotide Repeat Expansions in Fuchs Endothelial Corneal Dystrophy22
Transcript-Based Diagnosis and Expanded Phenotype of an Intronic Mutation in TPM3 Myopathy21
Development of a New Rapid Simultaneous Molecular Assay for the Detection of STI Pathogens and Drug Resistance-Associated Mutations20
Molecular Therapeutics in Development to Treat Alzheimer’s Disease19
Diagnosis of Lung Cancer Through Exhaled Breath: A Comprehensive Study19
Single Nucleotide Variants in KIF14 Gene May Have Prognostic Value in Breast Cancer18
Advances in Pompe Disease Treatment: From Enzyme Replacement to Gene Therapy18
In vivo LNP-CRISPR Approaches for the Treatment of Hemophilia17
Performance of a Rapid Digital PCR Test for the Detection of Non-Small Cell Lung Cancer (NSCLC) Variants17
The Diagnostic and Prognostic Value of miR-155 in Cancers: An Updated Meta-analysis17
The Emerging Role of Olfactory Receptors: From Genomics to Precision Medicine17
Targeted Therapy in Salivary Gland Cancer: Prevalence of a Selected Panel of Actionable Molecular Alterations in a German Tertiary Referral Center Patient Cohort17
Molecular Dynamics as a Precision Therapy: A Perspective on Epileptic Encephalopathies17
Evolutionary Overview and Future Perspectives: ESR1 Mutations, Liquid Biopsy, and Artificial Intelligence for a New Era of Personalized Medicine in ER+ Breast Cancer16
Selecting Targets for Molecular Imaging of Gastric Cancer: An Immunohistochemical Evaluation16
Correction to: Molecular Therapeutics in Development to Treat Alzheimer’s Disease16
Neuromuscular Junction as a Molecular Target in Sarcopenia: Mechanisms, Therapeutic Strategies, and Future Directions15
Is the Homologous Recombination Repair Mutation Defined by a 15-Gene Panel Associated with the Prognosis of Epithelial Ovarian Cancer?15
Role of lncRNAs in Remodeling of the Coronary Artery Plaques in Patients with Atherosclerosis14
Diagnostic Performance of the ASCL1/ZNF582 Methylation Test for Detection of High-Grade Vulvar Intraepithelial Neoplasia and Vulvar Cancer14
TROP2-Targeted Therapeutics in Development to Treat Gastrointestinal Tumors14
Correction: Recent Advancements in Nanomaterials: A Promising Way to Manage Neurodegenerative Disorders14
Cell-Free HPV-DNA in Screening, Diagnosis, Prognosis, and Treatment Response Monitoring of Cervical Cancer14
Lifileucel: First Approval14
The Role οf Ion Channels in the Development and Progression of Prostate Cancer14
Psoriasis: A Multidimensional Review of Onset, Progression, Treatment, and the Evolution of Disease Models13
Bridging the Gap: Cost-Effective Strategies for Detecting Ph-Like B-Lineage ALL in Resource-Limited Settings13
Comment on “Prognostic Value of Programmed Death Ligand-1 Expression in Solid Tumors Irrespective of Immunotherapy Exposure: A Systematic Review and Meta‑Analysis”13
Cytokines at the Crossroads of Mitochondrial Dysfunction and Inflammation in Colorectal Cancer: Implications for Postoperative Complications13
Emerging RNAi Therapies to Treat Hypertension12
Correction to: Exploratory Prognostic Biomarkers of Complement-Mediated Thrombotic Microangiopathy (CM-TMA) in Adults with Atypical Hemolytic Uremic Syndrome (aHUS): Analysis of a Phase III Study of R12
Correction to: Optimization of a Quantitative PCR Methodology for Detection of Aspergillus spp. and Rhizopus arrhizus12
Author reply to Wang et al.: “The Diagnostic and Prognostic Value of miR-155 in Cancers: An Updated Meta‑analysis”11
Human Papillomavirus Type and Viral Load in Relation to Circulating Cell-Free Tumour HPV DNA Level and Survival in Cervical Cancer11
Extracellular Histones Profiles of Pediatric H3K27-Altered Diffuse Midline Glioma11
Inner Ear Gene Therapy: An Overview from Bench to Bedside11
Chimeric Genes Causing 11β-Hydroxylase Deficiency: Implications in Clinical and Molecular Diagnosis11
Fluorescence Imaging-Assessed Surgical Margin Detection in Head and Neck Oncology by Passive and Active Targeting11
Retroviral Remnants in the Human Genome: Classification, Integration and Regulation11
Blood Biomarkers of Long COVID: A Systematic Review11
Exploratory Prognostic Biomarkers of Complement-Mediated Thrombotic Microangiopathy (CM-TMA) in Adults with Atypical Hemolytic Uremic Syndrome (aHUS): Analysis of a Phase III Study of Ravulizumab11
Obecabtagene Autoleucel: First Approval11
Methylation Analyses Reveal Promoter Hypermethylation as a Rare Cause of “Second Hit” in Germline BRCA1-Associated Pancreatic Ductal Adenocarcinoma11
Future Prospects for Epigenetics in Autism Spectrum Disorder11
0.46943712234497